AlphaCrest Capital Management LLC ACAD Holdings History
AlphaCrest Capital Management LLC's ACADIA Pharmaceuticals Inc Holding Summary
As of 2022-12-31, AlphaCrest Capital Management LLC held - shares of ACADIA Pharmaceuticals Inc(ACAD), totaling N/A. This investment constitutes 0% of their stock portfolio, and AlphaCrest Capital Management LLC now holds 0% of the outstanding ACADIA Pharmaceuticals Inc(ACAD) stock.
The initial trade took place in 2019Q3. And since then AlphaCrest Capital Management LLC has made 9 purchases of ACAD, at an average price of $30.39, for a total of 148,151.00 shares. In addition, there have been 5 sales at an average price of $22.84 for 148,151.00 shares. Based on historical transaction data and ACAD's current price of $23.27, AlphaCrest Capital Management LLC's estimated gain on his ACAD holdings is $-1.12 Mil, reflecting a -24.83% gain to date.
AlphaCrest Capital Management LLC ACAD ($23.27) Holding Chart
AlphaCrest Capital Management LLC ACAD ($23.27) Quarterly Buys and Sells
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
|---|---|---|---|---|
| Shares Bought | 0 | Average Price $-/Share | ||
| Shares Sold | 0 | Average Price $-/Share | ||
| Current Price $0.00 | Total Estimated Gain 0 % | |||
Top Ranked Articles
- 1
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
